EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CONSTRUCTION OF SIRI NOMOGRAM FOR PREDICTING UROLITHIASIS RISK IN PATIENTS WITH METABOLIC SYNDROME AND TEMPORAL EXTERNAL VALIDATION OF ITS DEVELOPMENT

FangMing Xu, QiMing Xu, ShuBin Cao, Li Yao, Min Xiong, Rajesh Kumar Yadav, Li Gao

Eurasia Journal of Science and Technology · 12.08.2026 · 8 (4) · 25-31

DOI: 10.61784/ejst3160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasia Journal of Science and Technology, online erschienen am 12.08.2026. Verfasst von FangMing Xu und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the relationship between systemic inflammatory markers and urolithiasis, and to build a reliable nomogram to predict the risk of patients.

Methods

A total of 878 patients were included in this study, and all of them were diagnosed with MetS and were admitted to the hospital between October 2022 and October 2025. All patients were divided into two groups, one with stones (n=246) and the other without stones (n=632). Logistic regression and LASSO regression were used to identify independent risk factors, and ROC curves, calibration plots, DCA and other methods were used to verify the effectiveness of the nomogram. In order to achieve temporal external validation, 111 patients were selected from other hospitals for analysis, and the study followed the TRIPOD statement.

Results

Seven variables were identified as independent predictors: gender, age, urinary uric acid, urinary citrate, hs-CRP, IL-6, and the systemic inflammatory response index (SIRI). The nomogram demonstrated good discriminative capacity with an AUC of 0.751 (95% CI: 0.716–0.787) in the derivation cohort and 0.725 (95% CI: 0.617–0.833) in the validation cohort. The calibration intercept was 0.048, indicating excellent agreement between the predicted and observed risks. Decision curve analysis (DCA) confirmed a significant clinical net benefit.

Conclusion

In the process of managing urolithiasis patients, the tool based on SIRI can play an important role, which is conducive to the implementation of personalized management and risk stratification.

Zitieren

APA

Xu, F., Xu, Q., Cao, S., Yao, L., Xiong, M., Yadav, R. K., & Gao, L. (2026). CONSTRUCTION OF SIRI NOMOGRAM FOR PREDICTING UROLITHIASIS RISK IN PATIENTS WITH METABOLIC SYNDROME AND TEMPORAL EXTERNAL VALIDATION OF ITS DEVELOPMENT. Eurasia Journal of Science and Technology, 8(4), 25-31. https://doi.org/10.61784/ejst3160

Vancouver

Xu F, Xu Q, Cao S, Yao L, Xiong M, Yadav RK, et al. CONSTRUCTION OF SIRI NOMOGRAM FOR PREDICTING UROLITHIASIS RISK IN PATIENTS WITH METABOLIC SYNDROME AND TEMPORAL EXTERNAL VALIDATION OF ITS DEVELOPMENT. Eurasia Journal of Science and Technology. 2026;8(4):25-31. doi:10.61784/ejst3160

BibTeX
@article{Xu2026,
  author = {Xu, FangMing and Xu, QiMing and Cao, ShuBin and Yao, Li and Xiong, Min and Yadav, Rajesh Kumar and Gao, Li},
  title = {CONSTRUCTION OF SIRI NOMOGRAM FOR PREDICTING UROLITHIASIS RISK IN PATIENTS WITH METABOLIC SYNDROME AND TEMPORAL EXTERNAL VALIDATION OF ITS DEVELOPMENT},
  journal = {Eurasia Journal of Science and Technology},
  year = {2026},
  volume = {8},
  number = {4},
  pages = {25--31},
  doi = {10.61784/ejst3160}
}
Kostenlos starten →